Motif Bio Plc (NASDAQ:MTFB) had its price objective increased by stock analysts at HC Wainwright to $32.00 in a research note issued on Wednesday, The Fly reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s target price suggests a potential upside of 216.55% from the stock’s previous close.

Separately, Zacks Investment Research upgraded shares of Motif Bio Plc from a “sell” rating to a “hold” rating in a report on Tuesday, June 27th.

Motif Bio Plc (NASDAQ MTFB) opened at 10.109 on Wednesday. The stock has a 50 day moving average price of $8.75 and a 200-day moving average price of $8.75. The stock’s market cap is $132.86 million. Motif Bio Plc has a 12 month low of $5.25 and a 12 month high of $10.63.

TRADEMARK VIOLATION WARNING: This story was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another website, it was illegally copied and reposted in violation of U.S. & international copyright & trademark legislation. The correct version of this story can be viewed at

The Fly

Receive News & Ratings for Motif Bio Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motif Bio Plc and related companies with's FREE daily email newsletter.